Dissecting and targeting SUMOylation to increase the efficacy of lymphoma immunotherapy
项目来源
德(略)基(略)F(略)
项目主持人
U(略)c(略)e(略)r(略)
项目受资助机构
未(略)
立项年度
2(略)
立项时间
未(略)
项目编号
5(略)6(略)9
项目级别
国(略)
研究期限
未(略) (略)
受资助金额
0(略)欧(略)
学科
H(略)t(略)g(略)n(略)o(略)
学科代码
未(略)
基金类别
R(略)a(略) (略)n(略)
关键词
未(略)
参与者
未(略)
参与机构
未(略)
项目标书摘要:Th(略)e post-tr(略) modifica(略)lular pro(略)e ubiquit(略)SUMO modi(略)lation)ha(略)s a cruci(略)ry mechan(略) key cell(略)ys.SUMO s(略) instrume(略)intenance(略)integrity(略) gene exp(略)l prolife(略)for immun(略) to vario(略)es.The ce(略)ylation s(略)htly cont(略)he balanc(略) of the m(略)nzymatic (略)ation mac(略)the SUMO (略)on pathwa(略)ns of SUM(略)is are fr(略)served in(略) associat(略)aggressiv(略) and poor(略)We previo(略)fied enha(略)ation as (略)ic vulner(略) B cell l(略))and soli(略)haracteri(略)ndency on(略)otein MYC(略)rom a tar(略)ning for (略)ted immun(略)echanisms(略)entified (略)nary cons(略)ion of ac(略)Oylation,(略)uates the(略)city of t(略)Activated(略)n allows (略)s to evad(略)l-mediate(略)veillance(略)sing the (略)en proces(略)esentatio(略)(APM).Whi(略)cy of the(略)is a freq(略)of resist(略)cer immun(略)the pharm(略)inhibitio(略)ation(SUM(略)oss of th(略)tional re(略)B and to (略)f the MHC(略)equently,(略)ced the p(略) of antig(略) suscepti(略)umor cell(略)cell medi(略)g.Importa(略)also trig(略)ctivation(略)ells itse(略)eby drive(略)rward loo(略)g the spe(略)tumor imm(略)e.We thus(略) activate(略)on conver(略)lls into (略)immune ev(略)dentify S(略)ional the(略)rategy fo(略) the effi(略)cer immun(略)To transl(略)cept of S(略)linical a(略)a precise(略)ing of th(略)s of SUMO(略)mmune esc(略) as effec(略)e cell ab(略) immune c(略)n is requ(略)e aim to (略)tumor-int(略)anisms of(略)SUMOylati(略) for immu(略)i)deciphe(略)of SUMOyl(略)ormation (略)sive tumo(略)ronment(T(略)luate in (略)uences of(略)in the TM(略)liver the(略)rategies (略)UMO-media(略)escape an(略)ssive TME(略)ation int(略)trials.
- (略)